logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kathryn E. Beckermann

Vanderbilt University Medical Center
H指数:33
被引数:7,837

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

高级泌尿肿瘤共识会议（AUC3）2025：肾细胞癌和尿路肿瘤管理的专家共识

CA: A Cancer Journal for Clinicians
IF0
2025-12-130
OAAI
Rana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma

I期b/II期研究：评估batiraxcept单药及联合cabozantinib（无论是否联合nivolumab）治疗晚期透明细胞肾细胞癌的疗效。

ONCOLOGIST
IF4.2
2025-06-010
PRE
Beckermann, Kathryn E.; Shah, Neil J.; Campbell, Matthew T.; Haas, Naomi B.; Nelson, Ariel; Ornstein, Moshe C.; Mao, Shifeng; Keshava-Prasad, Holavanahalli S.; Hammers, Hans; Gao, Xin; Gourdin, Theodore; George, Saby; Hoimes, Christopher J.; Hussain, Arif; Jonasch, Eric; Rini, Brian, I; Voss, Martin H.
Clinical and pathological outcomes of deferred nephrectomy in patients with metastatic and locally advanced RCC after immune checkpoint inhibitors

接受免疫检查点抑制剂治疗后，转移性及局部晚期肾细胞癌患者延迟性肾切除术的临床与病理结局

ONCOLOGIST
IF4.2
2025-04-040
OA
do Amaral, Paulo S.; Beckermann, Kathryn E.; Gordetsky, Jennifer B.; Chang, Sam S.; Joyce, Daniel D.; Schaffer, Kerry; Luckenbaugh, Amy N.; Lambrecht, Morgan A.; Ryan, Elizabeth G.; Barocas, Daniel A.; Moses, Kelvin A.; Rini, Brian, I
Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3TiNivo-2 Study

免疫检查点抑制剂后肾细胞癌患者Tivozanib联合nivolumab与tivozanib单药治疗的比较: 3TiNivo-2期研究的结果

LANCET
IF88.5
2024-10-014
PRE
Choueiri, Toni K.; Albiges, Laurence; Barthelemy, Philippe; Iacovelli, Roberto; Emambux, Sheik; Molina-Cerrillo, Javier; Garmezy, Benjamin; Barata, Pedro; Basu, Arnab; Bourlon, Maria; Moon, Helen; Ratta, Raffaele; McKay, Rana R.; Chehrazi-Raffle, Alexander; Hammers, Hans; Heng, Daniel Y. C.; Braendle, Edgar; Beckermann, Kathryn E.; McGregor, Bradley A.; Motzer, Robert J.
Tivozanibenivolumab vs tivozanib monotherapy in patients with renal cell carcinoma (RCC) following 1 or 2 prior therapies including an immune checkpoint inhibitor (ICI): Results of the phase III TiNivo-2 study

tivozanib联合enivolumab与tivozanib单药治疗在经1或2线含免疫检查点抑制剂（ICI）治疗的肾细胞癌（RCC）患者中的比较：TiNivo-2 III期研究的结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Choueiri, T. K.; Motzer, R. J.; Beckermann, K.; Barthelemy, P.; Iacovelli, R.; Emambux, S.; Cerrillo, J. Molina; Garmezy, B.; Barata, P. M. Coelho; McKay, R. R.; Chehrazi-Raffle, A.; Hammers, H.; Heng, D. Y. C.; Braendle, E.; McGregor, B. A.; Albiges, L.
Obesity induces PD-1 on macrophages to suppress anti-tumour immunity
Nature
IF48.5
2024-06-120
PRE
Jackie E. Bader; Melissa M. Wolf; Gian Luca Lupica-Tondo; Matthew Z. Madden; Bradley I. Reinfeld; Emily N. Arner; Emma S. Hathaway; KayLee K. Steiner; Gabriel A. Needle; Zaid Hatem; Madelyn D. Landis; Eden E. Faneuff; Amondrea Blackman; Elysa M. Wolf; Matthew A. Cottam; Xiang Ye; Madison E. Bates; Kyra Smart; Wenjun Wang; Laura V. Pinheiro; Anthos Christofides; DuPreez Smith; Vassiliki A. Boussiotis; Scott M. Haake; Kathryn E. Beckermann; Kathryn E. Wellen; Cynthia A. Reinhart-King; C. Henrique Serezani; Cheng-Han Lee; Christa Aubrey; Heidi Chen; W. Kimryn Rathmell; Alyssa H. Hasty; Jeffrey C. Rathmell
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability

人类肾细胞癌的代谢物分析揭示了营养物质的组织来源优势

ELIFE
IF0
2024-05-244
OA
Abbott, Keene L.; Ali, Ahmed; Reinfeld, Bradley, I; Deik, Amy; Subudhi, Sonu; Landis, Madelyn D.; Hongo, Rachel A.; Young, Kirsten L.; Kunchok, Tenzin; Nabel, Christopher S.; Crowder, Kayla D.; Kent, Johnathan R.; Madariaga, Maria Lucia L.; Jain, Rakesh K.; Beckermann, Kathryn E.; Lewis, Caroline A.; Clish, Clary B.; Muir, Alexander; Rathmell, W. Kimryn; Rathmell, Jeffrey; Vander Heiden, Matthew G.
VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis

VHL损失重新编程免疫景观以促进肾脏肿瘤发生中的炎性髓样微环境

JOURNAL OF CLINICAL INVESTIGATION
IF13.6
2024-04-152
OAAI
Wolf, Melissa M.; Madden, Matthew Z.; Arner, Emily N.; Bader, Jackie E.; Ye, Xiang; Vlach, Logan; Tigue, Megan L.; Landis, Madelyn D.; Jonker, Patrick B.; Hatem, Zaid; Steiner, KayLee K.; Gaines, Dakim K.; Reinfeld, Bradley I.; Hathaway, Emma S.; Xin, Fuxue; Tantawy, M. Noor; Haake, Scott M.; Jonasch, Eric; Muir, Alexander; Weiss, Vivian L.; Beckermann, Kathryn E.; Rathmell, W. Kimryn; Rathmell, Jeffrey C.
Kidney Cancer, Version 2.2024 Featured Updates to the NCCN Guidelines
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2024-02-0123
PRE
Motzer, Robert J.; Jonasch, Eric; Agarwal, Neeraj; Alva, Ajjai; Bagshaw, Hilary; Baine, Michael; Beckermann, Kathryn; Carlo, Maria I.; Choueiri, Toni K.; Costello, Brian A.; Derweesh, Ithaar H.; Desai, Arpita; Ged, Yasser; George, Saby; Gore, John L.; Gunn, Andrew; Haas, Naomi; Johnson, Michael; Kapur, Payal; King, Jennifer; Kyriakopoulos, Christos; Lam, Elaine T.; Lara, Primo N.; Lau, Clayton; Lewis, Bryan; Madoff, David C.; Manley, Brandon; Michaelson, M. Dror; Mortazavi, Amir; Ponsky, Lee; Ramalingam, Sundhar; Shuch, Brian; Smith, Zachary L.; Sosman, Jeffrey; Sweis, Randy; Zibelman, Matthew; Schonfeld, Ryan; Stein, MaryElizabeth; Gurski, Lisa A.
A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-02-013
OA
Beckermann, Kathryn E.; Bestvina, Christine M.; El Osta, Badi; Sanborn, Rachel E.; Borghaei, Hossein; Lammers, Philip Edward; Selvaggi, Giovanni; Whisenant, Jennifer G.; Heimann-Nichols, Ellen; Berry, Lynne; Hsu, Chih-Yuan; Shyr, Yu; Horn, Leora; Wakelee, Heather
Phase Ib/II study of batiraxcept (BT, AVB-S6-500, an AXL pathway inhibitor) in combination with cabozantinib (cabo) in patients with advanced clear cell renal cell carcinoma (ccRCC) who failed first-line (1L) therapy
ANNALS OF ONCOLOGY
IF65.4
2023-10-011
OAAI
Shah, N. J.; Campbell, M. T.; Mao, S.; Ornstein, M. C.; Haas, N. B.; Gao, X.; Hammers, H.; Keshava-Prasad, H.; Hoimes, C. J.; Hussain, A.; George, S.; Gourdin, T. S.; Nelson, A.; Yan, H.; Esquibel, V.; McIntyre, G.; Geller, R.; Voss, M. H.; Rini, B. I.; Beckermann, K.

研究方向

暂未获取到该数据
W
W. Kimryn Rathmell
H 指数:113论文数:546被引数:11.1万
B
Brian I. Rini
H 指数:122论文数:1,339被引数:7.7万
J
Jeffrey C. Rathmell
H 指数:99论文数:487被引数:4.0万
R
Rachel A. Hongo
H 指数:10论文数:29被引数:1,351
E
Eric Jonasch
H 指数:67论文数:624被引数:2.2万
B
Benjamin G. Vincent
H 指数:51论文数:455被引数:1.8万
S
Scott M. Haake
H 指数:20论文数:76被引数:3,309
N
Naomi B. Haas
H 指数:54论文数:539被引数:1.3万
H
Hans J. Hammers
H 指数:61论文数:403被引数:2.6万
M
Matthew D. Tucker
H 指数:19论文数:54被引数:2,207